White House pulls Trump’s FDA nominee on eve of key Senate vote - The Independent

Direct Source Verification: This story is aggregated from The Independent (independent.co.uk). Full reporting rights and copyright belong to the primary publisher.
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.

The White House has abruptly pulled the nomination of President Donald Trump’s choice to lead the Food and Drug Administration on the eve of a key Senate committee vote on her candidacy.

Dr Heidi Overton, a physician with a background in public health and a record of opposing abortion, has been serving as the deputy director of the White House’s Domestic Policy Council and was picked by the president for the job in August.

She was seen as a Trump loyalist who could bring stability to the agency that oversees drug safety, vaccines, tobacco and the majority of the U.S. food supply after its former commissioner, Marty Makary, stepped down in May and was replaced by Kyle Diamantas in an acting capacity.

Overton had been due to appear before the Senate Health, Labor and Pensions Committee for a vote Wednesday, at which she would have needed the support of all 12 of its Republican panellists to overcome Democratic opposition and advance her candidacy to a full floor vote.

However, her nomination was pulled late Tuesday with Trump officials having spent several days attempting to fend off threats from Missouri Republican Sen. Josh Hawley and other pro-lifers to sink her candidacy amid frustration with the administration dragging its feet on restricting the distribution of the abortion drug mifepristone, according to CNN.

Overton reportedly also faced opposition from conservatives on the other side of the abortion debate like Maine and Alaska GOP senators Susan Collins and Lisa Murkowski, who disapproved of her record on the issue and of her role in the administration approving fruit-flavored vapes.

Sources also told CNN that relations between Overton and Health and Human Services Secretary Robert F Kennedy Jr were “not good” and even “icy” and that her being withdrawn may reflect new White House Chief of Staff Stephen Miller’s preferences, given that she was backed by his predecessor Susie Wiles.

Her candidacy was meanwhile publicly opposed on the streets of Washington, D.C., through a poster campaign orchestrated by the watchdog Health in Office, which urged senators to “say no to Heidi Vaperton for FDA commissioner,” claiming she was “pro-big tobacco” and “pro-abortion ban,” according to The Washington Post.

A White House official confirmed to The Independent that Overton’s nomination had been pulled when approached for comment. The Independent also reached out to HHS for its response.

Louisiana GOP Sen. Bill Cassidy, a doctor and the Senate committee’s chair, expressed his surprise over Overton’s withdrawal in a post on X.

“Tonight, the White House abandoned a viable confirmation path for D. Overton,” he wrote. “The WH said that this was because she did not have the votes to pass.

“This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee and pass the full Senate. My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk.

“The last issue was that pro-life senators sought final assurances from the administration regarding the administration’s commitment to life issues. The administration withdrew Dr Overton rather than make such commitments.

“Unfortunately, with the limited time left, confirming a permanent FDA commissioner will fall to Senate Democrats.”

Cassidy reportedly met with Overton last week to allay his own concerns about her nomination, he having previously called her support for Trump’s plan to break up combination vaccines – including the measles, mumps and rubella shot – “almost disqualifying” and expressed doubts about her willingness to break with the president and RFK Jr.

Kennedy’s dislike of Overton was seemingly shared by members of his Make America Healthy Again movement, who feared she would not stand up to corporate interests and blamed her for the administration’s move to encourage the production of the weed killer glyphosate.

The decision to scrap her nomination was certainly met with gloating by Alex Clark, a conservative wellness influencer aligned with MAHA, who posted on X: “God sent a rainbow after the storm.”

​​Mini Timmaraju, the president and CEO of Reproductive Freedom for All, also welcomed the end of her candidacy, saying in a statement: “Heidi Overton posed a serious threat to the future of medication abortion access.

“Voters rejected that anti-abortion agenda nationwide, and our members kept the pressure on to tank her confirmation. If Republicans try to rush through another nominee who threatens our healthcare, we’re ready to keep fighting.”

Overton’s removal from contention follows previous setbacks that saw the White House forced to withdraw nominees to lead the Centers for Disease Control and Prevention and the Surgeon General’s Office over opposition from Senate Republicans.

Original Source
https://www.independent.co.uk/news/world/americas/us-politics/trump-heidi-overton-fda-rfk-jr-b3087172.html
Visit The Independent ↗
SHARE STORY:
𝕏 f in

Related Coverage in Health